Author:
Gevorkov A. R.,Boiko A. V.,Zavalishina L. E.,Chernichenko A. V.
Abstract
Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia The role of radiotherapy in treating head and neck tumors is on the increase, which is associated with a tendency for organ-saving treatment and with a need for a combination and comprehensive approach in case of locally advanced cancer. At the same time, only group prediction is already insufficient in clinical practice to define adequate treatment for these patients; and an individual approach to defining indications for radiotherapy is increasingly greater importance. Despite the fact that the generally accepted clinical and morphological parameters are rather informative in choosing an adequate local and systemic treatment; however, they are insufficiently individual. There is a need for putting into practice the new predictors of the efficiency of radiotherapy, which make it possible to optimize treatment policy, thus improving its results.
Reference59 articles.
1. Имянитов Е. Н., Хансон К. П. Молекулярная онкология: клинические аспекты. — СПб.: СПбМАПО, 2007.
2. Онкология: Национальное руководство / Под ред. В. И. Чиссова, М. И. Давыдова. — М.: ГЭОТАР-Медиа, 2008.
3. Матякин Е. Г., Алферов В. С. // Материалы 2-й ежегодной Российской онкологической конф. «Современные тенденции развития лекарственной терапии опухолей». — М., 1998.
4. Adelstein D. J., Li Y., Adams G. L. et al. // J. Clin. Oncol. — 2003. — Vol. 21, N 1. — P. 92—98.
5. Bartelink H., Horiot J. // Radiother. Oncol. — 2000. — Vol. 55. — P. 217—218.